Pre-morbid asociality in neuroleptic-resistant and neuroleptic-responsive schizophrenia

Psychological Medicine

Volumn 26, Issue 5, 1996, Pages 1033-1041

  Findling, R L ^b   Jayathilake, K ^b   Meltzer, H Y ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CHILDHOOD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; SCHIZOPHRENIA;

EID: 0029838909     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0033291700035352     Document Type: Article

References (29)

1. Bardenstein, K. K. & McGlashan, T. H. (1990). Gender differences in affective, schizoaffectivc and schizophrenic disorders: Schizophrenia Research 3, 159-172.
2. Bartkó, G., Frecska, E., Horvath, S., Zador, G. & Arato, M. (1990). Predicting neuroleptic response from a combination of multilevel variables in acute schizophrenic patients. Acta Psychiatrica Scandinavica 82, 408-412.
3. Brenner, H. D., Dencker, S. J., Goldstein, M. J., Hubbard, J. W., Keegen, D. L., Kruger, G., Kulhanek, F., Liberman, R. P., Malm, U. & Midha, K. K. (1990). Defining treatment refractoriness in schizophrenia. Schizophrenia Bulletin 16, 551-562.
4. Brown, W. A. & Herz, L. R. (1989). Response to neuroleptic drugs as a device for classifying schizophrenia. Schizophrenia Bulletin 25, 123-129.
5. Cannon-Spoor, H. E., Potkin, S. G. & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 8, 470-484.
6. Castle, D. J. & Murray, R. M. (1991). The neurodevelopmental basis of sex differences in schizophrenia. Psychological Medicine 21, 565-575.
7. Castle, D. J., Wessely, S. & Murray, R. M. (1993). Sex and schizophrenia: effects of diagnostic stringency, and associations with premorbid variables. British Journal of Psychiatry 162, 685-664.
8. Crow, T. J. (1980). Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280, 66-68.
9. Davis, J. M., Schaffer, C. B., Killian, G. A., Kinard, C. & Chan, C. (1980). Important issues in the drug treatment of schizophrenia Schizophrenia Bulletin 6, 70-87.
10. DeLisi, L. E., Dauphinais, I. D. & Hauser, P. (1989). Gender differences in the brain: are they relevant to the pathogenesis in schizophrenia? Comprehensive Psychiatry 30, 207-208.
11. Done, D. J, Crow, T. J., Johnstone, E. C. & Sacker, A. (1994). Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. British Medical Journal 309, 699-703.
12. Endicott, J. & Spitzer, R. L. (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35, 837-844.
13. Findling, R. L., Weishampel, P., Cola, P. A., Jayathilake, K. & Meltzer, H. Y. (1996). Childhood and adolescent psychosocial functioning in neuroleptic-resistant and neuroleptic-responsive adults with schizophrenia. (Submitted.)
14. Garmezy, M. (1968). Process and reactive schizophrenia: Some conceptions and issues. In The Role and Methodology of Classification in Psychiatry and Psychopathology (ed M. M. Katz, J. O. Cole and W. E. Barton) pp. 419-466. Superintendent of Documents. US Government Printing Office: Washington, DC.
15. Garmezy, N., with the collaboration of Strcitman, S. (1974). Children at risk: the search for the antecedents of schizophrenia. Part 1: Conceptual models and research methods. Schizophrenia Bulletin 1 (Experimental Issue No. 8), 14-90.
16. Gittleman-Klein, R. & Klein, D. F. (1969), Premorbid asocial adjustment and prognosis in schizophrenia. Journal of Psychiatry Research 7, 35-53.
17. Goldslein, J. M. (1988). Gender differences in the course of schizophrenia. American Journal of Psychiatry 145, 684-689.
18. Haas, G. & Sweeney, J. (1992). Premorbid and onset features of first episode schizophrenia. Schizophrenia Bulletin 18, 373-386.
19. Häfner, H., Riecher-Rössler, A., An Der Meisen, W., Maurer, K., Fatkenheuer, B. & Loffler, W. (1993). Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychological Medicine 23, 925-940.
20. Iselc, R., Merz, J., Malzacher, M. & Angst, J, (1985). Social disability in schizophrenia: the controlled prospective Burghozli study. II. Premorbid living situation and social adjustment-comparison with a normal control sample. European Archives of Psychiatry and Neurological Sciences 234, 348-356.
21. Kane, J., Honigfeld, G., Singer, J., Meltzer, H. Y. & the Clozaril Collaborative Study Group (1988). Clozapine for the treatment-resistant schizophrenic. Archives of General Psychiatry 45, 789-796.
22. Keefe, R. S. E., Mohs, R., Losonczy, M. F., Davidson, M., Silverman. J. M., Horvath, T. & Davis, K. L. (1989). Premorbid sociosexual functioning and long-term outcome in schizophrenia. American Journal of Psychiatry 146, 206-211.
23. Klein, D. F. Rosen, B. & Oaks, G. (1973). Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients. Arch Gen Psychiatry 29, 480-485.
24. Kolakowska, T., Williams, A. O., Reveley, M. A. & Ardern, M. (1985). Schizophrenia with good and poor outcome I: early clinical features, response to neuroleptics and signs of organic dysfunction. British Journal of Psychiatry 146, 229-246.
25. Lieberman, J. A. & Koreen, A. F. (1993). Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophrenia Bulletin 19, 371-429.
26. Meltzer, H. Y. (1991). The mechanism of action of novel antipsychotic drugs. Schizophrenia Bulletin. 17, 263-287.
27. Meltzer, H. Y., Rabinowitz, J., Lee, M. A., Thompson, P. A., Ranjan, R. & Findling, R. (1996). Age at onset and gender of schizophrenia in relation to neuroleptic-resistance. American Journal of Psychiatry (in the press).
28. Seeman, M. V. (1986). Current outcome in schizophrenia: women vs. men. Acta Psychiatrica Scandinavica 73, 609-617.
29. Wolkin, A., Barouche, F., Wolf, A. P., Rotrosen, J., Fowler, J. S., Shiue, C.-Y., Cooper, T. B. & Brodie, J. D. (1989). Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. American Journal of Psychiatry 146, 905-908.